ERBB2 and breast cancer: Multivariate serum analysis for MMP-9, together with the extracellular domain (ECD) of HER2 (HER2-ECD) and neuron-specific enolase (NSE) (a non-specific NE biomarker), was able to discriminate between BC patients for brain metastasis (Darlix et al., 2016).